nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—Methylprednisolone—ankylosing spondylitis	0.134	0.153	CbGbCtD
Sitagliptin—ABCB1—Betamethasone—ankylosing spondylitis	0.0873	0.0992	CbGbCtD
Sitagliptin—ABCB1—Prednisolone—ankylosing spondylitis	0.0861	0.0979	CbGbCtD
Sitagliptin—ABCB1—Prednisone—ankylosing spondylitis	0.0813	0.0924	CbGbCtD
Sitagliptin—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0804	0.0914	CbGbCtD
Sitagliptin—CYP2C8—Dexamethasone—ankylosing spondylitis	0.075	0.0852	CbGbCtD
Sitagliptin—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0609	0.0693	CbGbCtD
Sitagliptin—CYP3A4—Betamethasone—ankylosing spondylitis	0.0523	0.0594	CbGbCtD
Sitagliptin—CYP3A4—Prednisolone—ankylosing spondylitis	0.0516	0.0586	CbGbCtD
Sitagliptin—ABCB1—Dexamethasone—ankylosing spondylitis	0.0508	0.0577	CbGbCtD
Sitagliptin—CYP3A4—Prednisone—ankylosing spondylitis	0.0487	0.0554	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—ankylosing spondylitis	0.0408	0.0464	CbGbCtD
Sitagliptin—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0304	0.0346	CbGbCtD
Sitagliptin—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.000518	0.00432	CcSEcCtD
Sitagliptin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000515	0.00429	CcSEcCtD
Sitagliptin—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.000505	0.00421	CcSEcCtD
Sitagliptin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000503	0.00419	CcSEcCtD
Sitagliptin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000501	0.00417	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0005	0.00416	CcSEcCtD
Sitagliptin—Weight increased—Prednisone—ankylosing spondylitis	0.000499	0.00416	CcSEcCtD
Sitagliptin—Vision blurred—Prednisolone—ankylosing spondylitis	0.000496	0.00413	CcSEcCtD
Sitagliptin—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.000495	0.00412	CcSEcCtD
Sitagliptin—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000488	0.00406	CcSEcCtD
Sitagliptin—Depression—Prednisone—ankylosing spondylitis	0.000488	0.00406	CcSEcCtD
Sitagliptin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000486	0.00405	CcSEcCtD
Sitagliptin—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000483	0.00402	CcSEcCtD
Sitagliptin—Angioedema—Prednisolone—ankylosing spondylitis	0.000481	0.004	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00048	0.00399	CcSEcCtD
Sitagliptin—Breast disorder—Methotrexate—ankylosing spondylitis	0.00048	0.00399	CcSEcCtD
Sitagliptin—Malaise—Prednisolone—ankylosing spondylitis	0.000475	0.00395	CcSEcCtD
Sitagliptin—Vertigo—Prednisolone—ankylosing spondylitis	0.000473	0.00394	CcSEcCtD
Sitagliptin—Eye disorder—Betamethasone—ankylosing spondylitis	0.000471	0.00392	CcSEcCtD
Sitagliptin—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000471	0.00392	CcSEcCtD
Sitagliptin—Back pain—Triamcinolone—ankylosing spondylitis	0.000468	0.0039	CcSEcCtD
Sitagliptin—Angiopathy—Betamethasone—ankylosing spondylitis	0.000458	0.00381	CcSEcCtD
Sitagliptin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000458	0.00381	CcSEcCtD
Sitagliptin—Hypertension—Prednisolone—ankylosing spondylitis	0.000454	0.00378	CcSEcCtD
Sitagliptin—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00045	0.00374	CcSEcCtD
Sitagliptin—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000449	0.00374	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000448	0.00373	CcSEcCtD
Sitagliptin—Discomfort—Prednisolone—ankylosing spondylitis	0.000443	0.00369	CcSEcCtD
Sitagliptin—Angioedema—Triamcinolone—ankylosing spondylitis	0.000442	0.00368	CcSEcCtD
Sitagliptin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000441	0.00367	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00044	0.00366	CcSEcCtD
Sitagliptin—Malaise—Triamcinolone—ankylosing spondylitis	0.000436	0.00363	CcSEcCtD
Sitagliptin—Malaise—Methylprednisolone—ankylosing spondylitis	0.000435	0.00363	CcSEcCtD
Sitagliptin—Vertigo—Triamcinolone—ankylosing spondylitis	0.000435	0.00362	CcSEcCtD
Sitagliptin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000434	0.00361	CcSEcCtD
Sitagliptin—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000432	0.00359	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000429	0.00358	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000426	0.00355	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000422	0.00352	CcSEcCtD
Sitagliptin—Cough—Triamcinolone—ankylosing spondylitis	0.000422	0.00352	CcSEcCtD
Sitagliptin—Hypertension—Triamcinolone—ankylosing spondylitis	0.000418	0.00348	CcSEcCtD
Sitagliptin—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000417	0.00347	CcSEcCtD
Sitagliptin—Myalgia—Triamcinolone—ankylosing spondylitis	0.000412	0.00343	CcSEcCtD
Sitagliptin—Pneumonia—Methotrexate—ankylosing spondylitis	0.000411	0.00342	CcSEcCtD
Sitagliptin—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000411	0.00342	CcSEcCtD
Sitagliptin—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000411	0.00342	CcSEcCtD
Sitagliptin—Eye disorder—Prednisone—ankylosing spondylitis	0.00041	0.00342	CcSEcCtD
Sitagliptin—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00041	0.00341	CcSEcCtD
Sitagliptin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.000409	0.0034	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—ankylosing spondylitis	0.000409	0.0034	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000408	0.0034	CcSEcCtD
Sitagliptin—Depression—Methotrexate—ankylosing spondylitis	0.000408	0.00339	CcSEcCtD
Sitagliptin—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000407	0.00339	CcSEcCtD
Sitagliptin—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000407	0.00339	CcSEcCtD
Sitagliptin—Discomfort—Triamcinolone—ankylosing spondylitis	0.000407	0.00339	CcSEcCtD
Sitagliptin—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000406	0.00338	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000405	0.00338	CcSEcCtD
Sitagliptin—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000403	0.00335	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—ankylosing spondylitis	0.000402	0.00335	CcSEcCtD
Sitagliptin—Angioedema—Betamethasone—ankylosing spondylitis	0.000401	0.00334	CcSEcCtD
Sitagliptin—Angioedema—Dexamethasone—ankylosing spondylitis	0.000401	0.00334	CcSEcCtD
Sitagliptin—Angiopathy—Prednisone—ankylosing spondylitis	0.000399	0.00332	CcSEcCtD
Sitagliptin—Immune system disorder—Prednisone—ankylosing spondylitis	0.000397	0.0033	CcSEcCtD
Sitagliptin—Malaise—Betamethasone—ankylosing spondylitis	0.000396	0.0033	CcSEcCtD
Sitagliptin—Malaise—Dexamethasone—ankylosing spondylitis	0.000396	0.0033	CcSEcCtD
Sitagliptin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000395	0.00329	CcSEcCtD
Sitagliptin—Vertigo—Dexamethasone—ankylosing spondylitis	0.000394	0.00328	CcSEcCtD
Sitagliptin—Vertigo—Betamethasone—ankylosing spondylitis	0.000394	0.00328	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000394	0.00328	CcSEcCtD
Sitagliptin—Infection—Triamcinolone—ankylosing spondylitis	0.000392	0.00327	CcSEcCtD
Sitagliptin—Infection—Methylprednisolone—ankylosing spondylitis	0.000391	0.00326	CcSEcCtD
Sitagliptin—Insomnia—Prednisolone—ankylosing spondylitis	0.000388	0.00323	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000387	0.00322	CcSEcCtD
Sitagliptin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000386	0.00322	CcSEcCtD
Sitagliptin—Mental disorder—Prednisone—ankylosing spondylitis	0.000385	0.0032	CcSEcCtD
Sitagliptin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000383	0.00319	CcSEcCtD
Sitagliptin—Malnutrition—Prednisone—ankylosing spondylitis	0.000382	0.00318	CcSEcCtD
Sitagliptin—Hypertension—Betamethasone—ankylosing spondylitis	0.000379	0.00316	CcSEcCtD
Sitagliptin—Hypertension—Dexamethasone—ankylosing spondylitis	0.000379	0.00316	CcSEcCtD
Sitagliptin—Myalgia—Dexamethasone—ankylosing spondylitis	0.000374	0.00311	CcSEcCtD
Sitagliptin—Myalgia—Betamethasone—ankylosing spondylitis	0.000374	0.00311	CcSEcCtD
Sitagliptin—Anxiety—Dexamethasone—ankylosing spondylitis	0.000373	0.0031	CcSEcCtD
Sitagliptin—Anxiety—Betamethasone—ankylosing spondylitis	0.000373	0.0031	CcSEcCtD
Sitagliptin—Discomfort—Betamethasone—ankylosing spondylitis	0.000369	0.00307	CcSEcCtD
Sitagliptin—Discomfort—Dexamethasone—ankylosing spondylitis	0.000369	0.00307	CcSEcCtD
Sitagliptin—Pain—Prednisolone—ankylosing spondylitis	0.000367	0.00306	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000364	0.00303	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000363	0.00302	CcSEcCtD
Sitagliptin—Vision blurred—Prednisone—ankylosing spondylitis	0.00036	0.003	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00036	0.003	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00036	0.003	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000359	0.00299	CcSEcCtD
Sitagliptin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000358	0.00298	CcSEcCtD
Sitagliptin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000358	0.00298	CcSEcCtD
Sitagliptin—Insomnia—Triamcinolone—ankylosing spondylitis	0.000357	0.00297	CcSEcCtD
Sitagliptin—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000356	0.00297	CcSEcCtD
Sitagliptin—Infection—Dexamethasone—ankylosing spondylitis	0.000356	0.00296	CcSEcCtD
Sitagliptin—Infection—Betamethasone—ankylosing spondylitis	0.000356	0.00296	CcSEcCtD
Sitagliptin—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000355	0.00295	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000354	0.00295	CcSEcCtD
Sitagliptin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000351	0.00293	CcSEcCtD
Sitagliptin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000351	0.00293	CcSEcCtD
Sitagliptin—Angioedema—Prednisone—ankylosing spondylitis	0.000349	0.00291	CcSEcCtD
Sitagliptin—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000348	0.00289	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000347	0.00289	CcSEcCtD
Sitagliptin—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000347	0.00289	CcSEcCtD
Sitagliptin—Malaise—Prednisone—ankylosing spondylitis	0.000345	0.00287	CcSEcCtD
Sitagliptin—Vertigo—Prednisone—ankylosing spondylitis	0.000344	0.00286	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—ankylosing spondylitis	0.000343	0.00286	CcSEcCtD
Sitagliptin—Urticaria—Prednisolone—ankylosing spondylitis	0.000341	0.00284	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000341	0.00284	CcSEcCtD
Sitagliptin—Fatigue—Triamcinolone—ankylosing spondylitis	0.00034	0.00283	CcSEcCtD
Sitagliptin—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00034	0.00283	CcSEcCtD
Sitagliptin—Pain—Triamcinolone—ankylosing spondylitis	0.000338	0.00281	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—ankylosing spondylitis	0.000333	0.00277	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000332	0.00276	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000331	0.00275	CcSEcCtD
Sitagliptin—Hypertension—Prednisone—ankylosing spondylitis	0.00033	0.00275	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000326	0.00272	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000326	0.00272	CcSEcCtD
Sitagliptin—Myalgia—Prednisone—ankylosing spondylitis	0.000326	0.00271	CcSEcCtD
Sitagliptin—Arthralgia—Prednisone—ankylosing spondylitis	0.000326	0.00271	CcSEcCtD
Sitagliptin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000325	0.00271	CcSEcCtD
Sitagliptin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000325	0.0027	CcSEcCtD
Sitagliptin—Anxiety—Prednisone—ankylosing spondylitis	0.000324	0.0027	CcSEcCtD
Sitagliptin—Insomnia—Betamethasone—ankylosing spondylitis	0.000324	0.0027	CcSEcCtD
Sitagliptin—Insomnia—Dexamethasone—ankylosing spondylitis	0.000324	0.0027	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000323	0.00269	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000322	0.00268	CcSEcCtD
Sitagliptin—Discomfort—Prednisone—ankylosing spondylitis	0.000322	0.00268	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—ankylosing spondylitis	0.000322	0.00268	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—ankylosing spondylitis	0.00032	0.00266	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000316	0.00263	CcSEcCtD
Sitagliptin—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000315	0.00263	CcSEcCtD
Sitagliptin—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000315	0.00263	CcSEcCtD
Sitagliptin—Urticaria—Triamcinolone—ankylosing spondylitis	0.000314	0.00261	CcSEcCtD
Sitagliptin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000313	0.00261	CcSEcCtD
Sitagliptin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000312	0.0026	CcSEcCtD
Sitagliptin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000311	0.00259	CcSEcCtD
Sitagliptin—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000311	0.00259	CcSEcCtD
Sitagliptin—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000311	0.00259	CcSEcCtD
Sitagliptin—Infection—Prednisone—ankylosing spondylitis	0.00031	0.00258	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000309	0.00258	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000309	0.00258	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—ankylosing spondylitis	0.000309	0.00257	CcSEcCtD
Sitagliptin—Fatigue—Dexamethasone—ankylosing spondylitis	0.000309	0.00257	CcSEcCtD
Sitagliptin—Fatigue—Betamethasone—ankylosing spondylitis	0.000309	0.00257	CcSEcCtD
Sitagliptin—Pain—Betamethasone—ankylosing spondylitis	0.000306	0.00255	CcSEcCtD
Sitagliptin—Pain—Dexamethasone—ankylosing spondylitis	0.000306	0.00255	CcSEcCtD
Sitagliptin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000306	0.00255	CcSEcCtD
Sitagliptin—Skin disorder—Prednisone—ankylosing spondylitis	0.000303	0.00252	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—ankylosing spondylitis	0.000301	0.00251	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000296	0.00247	CcSEcCtD
Sitagliptin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000295	0.00246	CcSEcCtD
Sitagliptin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000295	0.00246	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000293	0.00244	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000293	0.00244	CcSEcCtD
Sitagliptin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000291	0.00242	CcSEcCtD
Sitagliptin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00029	0.00242	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—ankylosing spondylitis	0.000288	0.0024	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—ankylosing spondylitis	0.000287	0.00239	CcSEcCtD
Sitagliptin—Urticaria—Dexamethasone—ankylosing spondylitis	0.000285	0.00237	CcSEcCtD
Sitagliptin—Urticaria—Betamethasone—ankylosing spondylitis	0.000285	0.00237	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000284	0.00237	CcSEcCtD
Sitagliptin—Dizziness—Prednisolone—ankylosing spondylitis	0.000284	0.00236	CcSEcCtD
Sitagliptin—Asthenia—Triamcinolone—ankylosing spondylitis	0.000283	0.00236	CcSEcCtD
Sitagliptin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000283	0.00236	CcSEcCtD
Sitagliptin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000283	0.00236	CcSEcCtD
Sitagliptin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000283	0.00235	CcSEcCtD
Sitagliptin—Insomnia—Prednisone—ankylosing spondylitis	0.000282	0.00235	CcSEcCtD
Sitagliptin—Cough—Methotrexate—ankylosing spondylitis	0.000279	0.00232	CcSEcCtD
Sitagliptin—Dyspepsia—Prednisone—ankylosing spondylitis	0.000275	0.00229	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—ankylosing spondylitis	0.000272	0.00227	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—ankylosing spondylitis	0.000272	0.00227	CcSEcCtD
Sitagliptin—Decreased appetite—Prednisone—ankylosing spondylitis	0.000271	0.00226	CcSEcCtD
Sitagliptin—Rash—Prednisolone—ankylosing spondylitis	0.000271	0.00225	CcSEcCtD
Sitagliptin—Dermatitis—Prednisolone—ankylosing spondylitis	0.000271	0.00225	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00027	0.00225	CcSEcCtD
Sitagliptin—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00027	0.00224	CcSEcCtD
Sitagliptin—Fatigue—Prednisone—ankylosing spondylitis	0.000269	0.00224	CcSEcCtD
Sitagliptin—Headache—Prednisolone—ankylosing spondylitis	0.000269	0.00224	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—ankylosing spondylitis	0.000269	0.00224	CcSEcCtD
Sitagliptin—Constipation—Prednisone—ankylosing spondylitis	0.000267	0.00222	CcSEcCtD
Sitagliptin—Dizziness—Triamcinolone—ankylosing spondylitis	0.000261	0.00217	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000261	0.00217	CcSEcCtD
Sitagliptin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000261	0.00217	CcSEcCtD
Sitagliptin—Infection—Methotrexate—ankylosing spondylitis	0.000259	0.00216	CcSEcCtD
Sitagliptin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000257	0.00214	CcSEcCtD
Sitagliptin—Asthenia—Betamethasone—ankylosing spondylitis	0.000257	0.00214	CcSEcCtD
Sitagliptin—Asthenia—Dexamethasone—ankylosing spondylitis	0.000257	0.00214	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000256	0.00213	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000255	0.00212	CcSEcCtD
Sitagliptin—Nausea—Prednisolone—ankylosing spondylitis	0.000255	0.00212	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—ankylosing spondylitis	0.000253	0.00211	CcSEcCtD
Sitagliptin—Vomiting—Triamcinolone—ankylosing spondylitis	0.000251	0.00209	CcSEcCtD
Sitagliptin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000251	0.00209	CcSEcCtD
Sitagliptin—Rash—Triamcinolone—ankylosing spondylitis	0.000249	0.00207	CcSEcCtD
Sitagliptin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000249	0.00207	CcSEcCtD
Sitagliptin—Rash—Methylprednisolone—ankylosing spondylitis	0.000248	0.00207	CcSEcCtD
Sitagliptin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000248	0.00207	CcSEcCtD
Sitagliptin—Urticaria—Prednisone—ankylosing spondylitis	0.000248	0.00206	CcSEcCtD
Sitagliptin—Headache—Triamcinolone—ankylosing spondylitis	0.000247	0.00206	CcSEcCtD
Sitagliptin—Headache—Methylprednisolone—ankylosing spondylitis	0.000247	0.00206	CcSEcCtD
Sitagliptin—Abdominal pain—Prednisone—ankylosing spondylitis	0.000247	0.00205	CcSEcCtD
Sitagliptin—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000245	0.00204	CcSEcCtD
Sitagliptin—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000245	0.00204	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000238	0.00198	CcSEcCtD
Sitagliptin—Dizziness—Dexamethasone—ankylosing spondylitis	0.000237	0.00197	CcSEcCtD
Sitagliptin—Dizziness—Betamethasone—ankylosing spondylitis	0.000237	0.00197	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—ankylosing spondylitis	0.000236	0.00196	CcSEcCtD
Sitagliptin—Nausea—Triamcinolone—ankylosing spondylitis	0.000235	0.00195	CcSEcCtD
Sitagliptin—Nausea—Methylprednisolone—ankylosing spondylitis	0.000234	0.00195	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—ankylosing spondylitis	0.000232	0.00193	CcSEcCtD
Sitagliptin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00023	0.00191	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00023	0.00191	CcSEcCtD
Sitagliptin—Vomiting—Dexamethasone—ankylosing spondylitis	0.000228	0.0019	CcSEcCtD
Sitagliptin—Vomiting—Betamethasone—ankylosing spondylitis	0.000228	0.0019	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000227	0.00189	CcSEcCtD
Sitagliptin—Rash—Dexamethasone—ankylosing spondylitis	0.000226	0.00188	CcSEcCtD
Sitagliptin—Rash—Betamethasone—ankylosing spondylitis	0.000226	0.00188	CcSEcCtD
Sitagliptin—Dermatitis—Betamethasone—ankylosing spondylitis	0.000226	0.00188	CcSEcCtD
Sitagliptin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000226	0.00188	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000225	0.00187	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—ankylosing spondylitis	0.000225	0.00187	CcSEcCtD
Sitagliptin—Headache—Betamethasone—ankylosing spondylitis	0.000224	0.00187	CcSEcCtD
Sitagliptin—Headache—Dexamethasone—ankylosing spondylitis	0.000224	0.00187	CcSEcCtD
Sitagliptin—Asthenia—Prednisone—ankylosing spondylitis	0.000224	0.00186	CcSEcCtD
Sitagliptin—Pain—Methotrexate—ankylosing spondylitis	0.000223	0.00186	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000215	0.00179	CcSEcCtD
Sitagliptin—Diarrhoea—Prednisone—ankylosing spondylitis	0.000214	0.00178	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000213	0.00178	CcSEcCtD
Sitagliptin—Nausea—Betamethasone—ankylosing spondylitis	0.000213	0.00177	CcSEcCtD
Sitagliptin—Nausea—Dexamethasone—ankylosing spondylitis	0.000213	0.00177	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—ankylosing spondylitis	0.000207	0.00173	CcSEcCtD
Sitagliptin—Dizziness—Prednisone—ankylosing spondylitis	0.000206	0.00172	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000206	0.00172	CcSEcCtD
Sitagliptin—Vomiting—Prednisone—ankylosing spondylitis	0.000198	0.00165	CcSEcCtD
Sitagliptin—Rash—Prednisone—ankylosing spondylitis	0.000197	0.00164	CcSEcCtD
Sitagliptin—Dermatitis—Prednisone—ankylosing spondylitis	0.000197	0.00164	CcSEcCtD
Sitagliptin—Headache—Prednisone—ankylosing spondylitis	0.000195	0.00163	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000192	0.0016	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—ankylosing spondylitis	0.000187	0.00156	CcSEcCtD
Sitagliptin—Nausea—Prednisone—ankylosing spondylitis	0.000185	0.00154	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000178	0.00149	CcSEcCtD
Sitagliptin—Dizziness—Methotrexate—ankylosing spondylitis	0.000172	0.00144	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—ankylosing spondylitis	0.000166	0.00138	CcSEcCtD
Sitagliptin—Rash—Methotrexate—ankylosing spondylitis	0.000164	0.00137	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—ankylosing spondylitis	0.000164	0.00137	CcSEcCtD
Sitagliptin—Headache—Methotrexate—ankylosing spondylitis	0.000163	0.00136	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—ankylosing spondylitis	0.000155	0.00129	CcSEcCtD
